Virus Filtration Market Size, Share, Industry, Forecast and outlook (2026-2035)

Virus Filtration Market is segmented By Product (Consumables, Instruments, Services, Others), By Application (Biological, Medical Devices, Water Purification, Air Purification, Other), By End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutes, Other) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Last Updated: || Author: Akshay Reddy || Reviewed: Akshay Reddy || SKU: LE4823

Buy any syndicated report and get free complimentary customization of up to 20% of the Report and an interactive dashboard.

Report Summary
Table of Contents
List of Tables & Figures

Report Overview

The Global Virus Filtration Market size is estimated at US$ 5.93 billion in 2025 and is projected to reach US$ 18.74 billion by 2035, growing at a CAGR of 12.2% during the forecast period 2026-2035.

The virus filtration phase must be validated using simulated worst-case processing conditions to meet regulatory requirements. Virus filtration is one of the primary unit activities used to ensure the viral safety of biopharmaceutical processes by employing a strong size-exclusion mechanism. 

Virus filtration is an effective method for ensuring virus safety during biotherapeutic manufacturing procedures. This procedure separates viruses based on size and is an important component of viral safety assurance in downstream processing.

Market Scope

Metrics

Details

CAGR

12.2%

Market Size Available for Years

2025-2035

Estimation Forecast Period

2026-2035

Revenue Units

Value (US$ Mn) 

Segments Covered

Product, Application, End-User

Regions Covered

North America, Europe, Asia-Pacific, South America, and Middle East & Africa

Largest Region

North America

Fastest Growing Region

Asia-Pacific

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.

For more details on this report - Request for Sample

Market Dynamics: Drivers & Restraints

Increasing research and development    

The increasing research and developmental activities are expected to drive the market. Pharmaceutical, biotechnology and biopharmaceutical companies are increasingly researching to innovate new biologics or drugs and other products. Virus filtration has been an important step in these procedures. 

With the rising research and development, there is an increasing demand for virus filtration systems and kits and reagents. For instance, according to the publication by the UNESCO UIS in 2022, global spending on R&D has reached a record high of almost US$ 1.7 trillion. About 10 countries account for 80% of spending. 

Increasing focus on the development of innovative products is driving the researchers to conduct studies that are directly driving the market growth. Thus, the above factors are expected to drive the market growth.

High costs of virus filtration systems  

The high costs of virus filtration systems are expected to hinder the market growth. The initial investment by the companies for the development of a drug or any biologics is associated with huge expenses. The high cost of virus filtration systems can reduce the adoption of these systems by medium and small-sized companies.

Market Segment Analysis

The global virus filtration market is segmented based on product, application, end-user and region.

Filtration systems segment is expected to dominate the market share

The filtration systems are expected to hold a significant portion of the market share. The increasing investments by pharmaceutical and biopharmaceutical companies necessitate advanced filtration systems in research. As the research and developmental activities increase, the need for virus filtration systems increases.

The increasing technological advancements in the filtration systems and innovation of advanced and efficient virus filtration systems drive the segment growth. These factors encourage the companies to adopt these systems. Thus, the above factors are expected to hold the segment in the dominant position. 

Market Geographical Share

North America is expected to hold a significant position in the virus filtration market share

North America is expected to hold a significant position in the global virus filtration market during the forecast period due to the increasing production of biopharmaceutical and pharmaceutical production in the region, increasing technological advancements and the presence of a large number of market players.

The rise in the manufacturing of biologics and other biopharmaceutical products is considered to be the main factor for the market growth in the region. For instance, on October 1, 2024, Johnson & Johnson announced an investment of more than $2 billion to build a state-of-the-art biologics manufacturing facility in Wilson, North Carolina to expand the production of the company’s portfolio and pipeline of innovative biologics in support of Johnson & Johnson’s broader plan to advance more than 70 novel therapy and product expansion filings and launches by the end of the decade.

Additionally, on May 24, 2024, Eli Lilly and Company announced that it has more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 billion commitment, increasing the company's total investment in this site from $3.7 billion to $9 billion. This increases Lilly's capacity to manufacture active pharmaceutical ingredients (API) for various products. Thus, the above factors are expected to hold the region in a significant position in the market share. 

Recent Developments in the Global Virus Filtration Market

  •  Asahi Kasei expands Planova FG1 filter capacity: In October 2026, Asahi Kasei Life Science announced the commercial availability of a 1.0 m² Planova FG1 virus removal filter. The larger membrane area is designed to support higher processing volumes in commercial biopharmaceutical manufacturing while maintaining virus removal performance.
  • Asahi Kasei introduces a benchtop virus filtration system: In September 2026, Asahi Kasei Bioprocess announced the VANTIJ SU VFC Benchtop system for laboratory scale and process development applications. The automated, single use platform is designed to improve consistency and simplify virus filtration workflows during gene therapy manufacturing development.
  • Regulatory focus remains on viral safety: The US Food and Drug Administration's ICH Q5A(R2) guidance outlines risk based principles for evaluating and controlling viral contamination in biotechnology products derived from human or animal cell lines. This framework continues to inform viral safety assessments and validation strategies used in biopharmaceutical manufacturing.

Market Competitive Landscape

The major global players in the market include Asahi Kasei Medical Co., Ltd., Merck KgaA, Sartorius Group, Agilitech, Cytiva, Stellar Scientific, and Cygnus Technologies among others.

Why Purchase the Report?

  • To visualize the global virus filtration market segmentation based on product, application, end-user, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development. 
  • Excel data sheet with numerous data points of virus filtration market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global virus filtration market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Save 31% on all licenses
Single User$4350$2999Corporate$7850$5412

Free 20% customization + dashboard

Trusted by Global Leaders

ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
FAQ’s

  • Key players are Asahi Kasei Medical Co., Ltd., Merck KgaA, Sartorius Group, Agilitech, Cytiva, Stellar Scientific, and Cygnus Technologies.

  • North America leads, with Asia-Pacific as the fastest-growing region.

  • Rise in biologics production, stringent regulatory viral safety standards, and technology advancements.

  • Biologicals and biopharmaceutical manufacturing dominate application demand.

  • The market is estimated at approximately US$5.93 billion in 2025, calculated using the supplied 2023 market value and 12.2% CAGR.

  • The supplied market data states a CAGR of 12.2%. The 2025 and 2035 estimates use this rate as a calculation assumption.

  • The market is projected to reach approximately US$18.74 billion by 2035 under the same assumed growth rate.
What Our Clients Say About this Report
Dr. Meera Nair
Bioprocess Research Consultant
26 Aug, 2026
5/5
The virus filtration market is closely linked to the need for reliable viral safety throughout biopharmaceutical production. Manufacturers must evaluate filter performance, product recovery, throughput, and compatibility with the overall process. Advances in membrane design and automated filtration equipment may help development teams improve process consistency while meeting rigorous quality expectations. For market analysis, it is important to distinguish technical innovation from demonstrated improvements in manufacturing performance.
PDF
DataM
Virus Filtration Market Report
SKU: LE4823

Data-Backed Decisions Start Here

Explore how our research empowers industry leaders to cut through uncertainty. Get a free sample of this report or tailor it precisely to your business needs.

ISO 27001 Certified
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
Related Reports